Daily non-political popular news in brief.

More insight into Alzheimer's disease with Stanford discovery of possible cause

11-20-2006 · EurekAlert!

Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease.

Keywords: insight, alzheimer, disease, stanford, discovery, possible, cause

« Previous | Next »

Similar news on "More insight into Alzheimer's disease with Stanford discovery of possible cause":

A possible route to preventing Alzheimer's cognitive decline?
09-05-2007 · EurekAlert!
In experiments with mice, researchers have discovered a mechanism by which the toxic brain protein produced in Alzheimer’s disease (AD) could contribute to the cognitive deficits that are its hallmark. They found evidence that the toxic protein, called Aâ peptide, triggers overexcitation of neurons in the brain’s learning centers, inducing compensatory rewiring of brain circuitry in the centers—all of which could cause deterioration of neural function.
Similar news · Read more »
Scientists discover zinc link to a leading cause of blindness
03-22-2007 · EurekAlert!
Scientists at the University of Texas Medical Branch at Galveston and Neurobiotex, Inc. have found high levels of zinc in amyloid plaque deposits in the eye that are an indication of age-related macular degeneration (AMD). The discovery marks an additional similarity between AMD plaques and those seen in Alzheimer's disease and could facilitate the development of effective treatments for AMD.
Similar news · Read more »
Story ideas from the Journal of Biological Chemistry
05-24-2007 · EurekAlert!
Story ideas from the June 1, 2007, issue of the Journal of Biological Chemistry include how curry spice helps fight cancer; how tau proteins cause Alzheimer's disease; what causes amyotrophic lateral sclerosis; and new insight into cell division.
Similar news · Read more »
Alzheimer's prevention role discovered for prions
07-03-2007 · EurekAlert!
A role for prion proteins, the much debated agents of mad cow disease and vCJD, has been identified. It appears that the normal prions produced by the body help to prevent the plaques that build up in the brain to cause Alzheimer’s disease. The possible function for the mysterious proteins was discovered by a team of scientists led by Medical Research Council funded scientist Professor Nigel Hooper of the University of Leeds.
Similar news · Read more »
Story ideas from the Journal of Lipid Research
05-03-2007 · EurekAlert!
Story ideas from the May 2007 issue of the Journal of Lipid Research include why fish and seafood are better than olive oil and nuts against heart disease; too much cholesterol in a cell organelle can cause heart disease; why Down Syndrome individuals develop Alzheimer's disease earlier than the general population; and how lipids anchor proteins on cell membranes.
Similar news · Read more »
A possible mechanistic link between stress and the development of Alzheimer tangles
06-14-2007 · EurekAlert!
Subjecting mice to repeated emotional stress, the kind we experience in everyday life, may contribute to the accumulation of neurofibrillary tangles, one of the hallmarks of Alzheimer’s disease, report researchers at the Salk Institute for Biological Studies.
Similar news · Read more »
Model found to determine cause, possible treatment of nerve tumors
02-04-2008 · EurekAlert!
A multi-institutional study led by Cincinnati Children's Hospital Medical Center has led to new insights and a model to help unravel the cause of fibrous, noncancerous nerve tumors called neurofibromas, which can lead to disfigurement and in rare cases death by compressing vital organs. Writing for the February Cancer Cell, researchers said their findings also provide a way to test therapies that could eventually help patients with limited options for treating the disease -- Neurofibromatosis type 1.
Similar news · Read more »
Decreased TGF-beta signaling might make you demented
11-01-2006 · EurekAlert!
The physical changes that occur in the brain of patients with Alzheimer's disease, the most common cause of dementia in the elderly, have been well-characterized, but the cause(s) of this disease and the development of therapies has remained elusive. A new study now shows that decreased signaling through a receptor known as T-beta-RII -- expression of which is decreased in the neurons of patients with AD -- increases neurodegeneration in mice.
Similar news · Read more »
Alzheimer's-associated enzyme can disrupt neural activity in the brain
06-17-2007 · EurekAlert!
An enzyme involved in the formation of the amyloid-beta protein associated with Alzheimer's disease can also alter the mechanism by which signals are transmitted between brain cells, the disruption of which can cause seizures. These findings from researchers at the MassGeneral Institute for Neurodegenerative Disorders may explain the increased incidence of seizures in Alzheimer's patients, and suggest that potential treatments that block this enzyme may alleviate their occurrence
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »